Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Mazzucchelli

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
World Journal of Urology|December 24, 2015
Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patientsAlessandro Conti, Matteo Santoni, Luciano Burattini, et al.
Urologic Oncology|July 26, 2011
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometryRodolfo Montironi, Peter H Bartels, Andrea DeCensi, et al.
Anticancer Research|November 14, 2013
VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinomaDaniele Minardi, Guendalina Lucarini, Matteo Santoni, et al.
European Urology|June 14, 2015
Current Histopathologic and Molecular Characterisations of Prostate Cancer: Towards Individualised Prognosis and TherapiesMatteo Santoni, Marina Scarpelli, Roberta Mazzucchelli, et al.
Cancer Treatment Reviews|March 15, 2016
Metabolic phenotype of bladder cancerFrancesco Massari, Chiara Ciccarese, Matteo Santoni, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|April 13, 2007
Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potentialRodolfo Montironi, Marina Scarpelli, Antonio Lopez-Beltran, et al.
Current Drug Metabolism|October 16, 2015
Metabolic Alterations in Renal and Prostate CancerChiara Ciccarese, Matteo Santoni, Francesco Massari, et al.
Cancers|May 25, 2024
Diagnostic Biomarkers in Renal Cell Tumors According to the Latest WHO Classification: A Focus on Selected New EntitiesFrancesca Sanguedolce, Roberta Mazzucchelli, Ugo Giovanni Falagario, et al.
Urologic Oncology|June 6, 2022
A magnetic resonance imaging-based nomogram for predicting clinically significant prostate cancer at radical prostatectomyDaniele Castellani, Sara Cecchini, Roberta Mazzucchelli, et al.
Future Oncology (London, England)|December 11, 2020
Predicting future cancer burden in the United States by artificial neural networksFrancesco Piva, Francesca Tartari, Matteo Giulietti, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
World Journal of Urology|December 24, 2015
Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patientsAlessandro Conti, Matteo Santoni, Luciano Burattini, et al.
Urologic Oncology|July 26, 2011
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometryRodolfo Montironi, Peter H Bartels, Andrea DeCensi, et al.
Anticancer Research|November 14, 2013
VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinomaDaniele Minardi, Guendalina Lucarini, Matteo Santoni, et al.
European Urology|June 14, 2015
Current Histopathologic and Molecular Characterisations of Prostate Cancer: Towards Individualised Prognosis and TherapiesMatteo Santoni, Marina Scarpelli, Roberta Mazzucchelli, et al.
Cancer Treatment Reviews|March 15, 2016
Metabolic phenotype of bladder cancerFrancesco Massari, Chiara Ciccarese, Matteo Santoni, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|April 13, 2007
Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potentialRodolfo Montironi, Marina Scarpelli, Antonio Lopez-Beltran, et al.
Current Drug Metabolism|October 16, 2015
Metabolic Alterations in Renal and Prostate CancerChiara Ciccarese, Matteo Santoni, Francesco Massari, et al.
Cancers|May 25, 2024
Diagnostic Biomarkers in Renal Cell Tumors According to the Latest WHO Classification: A Focus on Selected New EntitiesFrancesca Sanguedolce, Roberta Mazzucchelli, Ugo Giovanni Falagario, et al.
Urologic Oncology|June 6, 2022
A magnetic resonance imaging-based nomogram for predicting clinically significant prostate cancer at radical prostatectomyDaniele Castellani, Sara Cecchini, Roberta Mazzucchelli, et al.
Future Oncology (London, England)|December 11, 2020
Predicting future cancer burden in the United States by artificial neural networksFrancesco Piva, Francesca Tartari, Matteo Giulietti, et al.
Pageof 18